RxDoctor Payments Data

Hayley Lynam

Physician Assistant · Corona, CANPI 1003357344

Payments from drug & device makers

$3,892in general payments, 2019–2025

Across 230 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$999
  • Novo Nordisk$546
  • AstraZeneca$535
  • AbbVie$240
  • Lilly USA, LLC$237
  • GSK$172
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,892100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,892 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$68,222
JardianceEmpagliflozin46$50,434
OzempicSemaglutide43$44,211
FarxigaDapagliflozin Propanediol20$27,795
MounjaroTirzepatide24$24,483
JanuviaSitagliptin Phosphate12$7,312
Wixela InhubFluticasone Propion/Salmeterol23$3,051
Levothyroxine Sodium173$2,019
Atorvastatin Calcium213$1,859
Rosuvastatin Calcium98$1,628
Gabapentin95$1,615
SynthroidLevothyroxine Sodium19$1,414
Omeprazole72$1,404
Pantoprazole Sodium131$1,293
Metformin Hcl135$1,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$22$68,22255 claims
Boehringer IngelheimJardiance$77$50,43446 claims
Novo NordiskOzempic$546$44,21143 claims
AstraZenecaFarxiga$535$27,79520 claims
Lilly USA, LLCMounjaro$237$24,48324 claims
MerckJanuvia$12$7,31212 claims
AbbVieSynthroid$240$1,41419 claims
Almatica Pharma LLCSertraline Hcl$71$41140 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Corona

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →